FI
Therapeutic Areas
Clerio Vision Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Presbyopia-Correcting Contact Lenses | Presbyopia | Development |
| Myopia Control Therapeutic Lenses | Myopia Progression | Development |
| Post-Implant IOL Adjustment | Post-Cataract Refractive Error | Development |
| Incisionless Laser Vision Correction | Refractive Errors (Myopia, Hyperopia, Astigmatism) | Development |
Leadership Team at Clerio Vision
JM
J. Mikael Totterman
Chairman
AZ
Alex Zapesochny
CEO
AS
Anna Schreyer
EVP of Development Operations
AS
Alissa Seidman
EVP of Finance
LZ
Len Zheleznyak, PhD
EVP of Vision Science
LX
Lisen Xu, PhD
VP of Applied Research
WK
Wayne Knox, PhD
Chief Scientific Officer